Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
| Title : The dipeptidyl peptidase IV inhibitor vildagliptin suppresses endogenous glucose production and enhances islet function after single-dose administration in type 2 diabetic patients - Balas_2007_J.Clin.Endocrinol.Metab_92_1249 |
| Author(s) : Balas B , Baig MR , Watson C , Dunning BE , Ligueros-Saylan M , Wang Y , He YL , Darland C , Holst JJ , Deacon CF , Cusi K , Mari A , Foley JE , DeFronzo RA |
| Ref : J Clinical Endocrinology Metab , 92 :1249 , 2007 |
| Abstract : Balas_2007_J.Clin.Endocrinol.Metab_92_1249 |
| ESTHER : Balas_2007_J.Clin.Endocrinol.Metab_92_1249 |
| PubMedSearch : Balas_2007_J.Clin.Endocrinol.Metab_92_1249 |
| PubMedID: 17244786 |